Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, will be hosting a Private Shareholder event on Wednesday, 15 November 2017 at 2.00 pm until 4.00 pm at finnCap’s offices, 60 New Broad St, London EC2M 1JJ and will take the form of a Company presentation to update shareholders on progress followed by a Q&A session.
The presentation for the event will also be made available on the Company’s website.
Investors and shareholders who wish to attend the event should register their interest at: investorevents@avacta.com.